doi: 10.1507/endocrj.43.suppl_s57 54 MllerNJrgensenJOL
Why the Ipamorelin and Tesamorelin Blend Works: GHRH + GHRP Synergy Heres where the pharmacology gets exciting
The question that matters clinically is whether a given patient is a good candidate, what the right protocol looks like for their specific goals and lab results, and whether they have access to a supervised framework that can catch the small number of patients for whom these compounds are not appropriate before they start rather than after
Most people see their strongest results during this phase
For an injectable peptide, those are not minor concerns
Common side effects by peptide type Growth hormone peptides Examples : Ipamorelin, CJC-1295, GHRP-2, GHRP-6, Hexarelin Common side effects (usually mild and temporary): Water retention : Frequency: 20-30% of users Severity: Mild Duration: 1-2 weeks (resolves as body adapts) Why: GH increases fluid retention temporarily Management: Reduce sodium, stay hydrated Increased appetite : Frequency: 30-50% with GHRP-6, less with Ipamorelin Severity: Mild to moderate Duration: 1-2 hours post-injection Why: Ghrelin receptor activation (hunger hormone) Management: Time injections strategically Tiredness post-injection : Frequency: 10-20% of users (first week) Severity: Mild Duration: 30-60 minutes after injection Why: Body adjusting to increased GH Management: Resolves within 1-2 weeks Joint discomfort : Frequency: 5-10% of users (rare) Severity: Mild Duration: Temporary with continued use Why: Increased fluid in joints Management: Reduce dose temporarily Numbness/tingling (hands/feet): Frequency: 5% of users (rare) Severity: Mild Duration: Temporary Why: Mild carpal tunnel from water retention Management: Usually resolves, reduce dose if persistent Read our complete Ipamorelin vs CJC-1295 guide
